StockNews.com assumed coverage on shares of Axon Enterprise (NASDAQ:AXON – Free Report) in a report issued on Wednesday morning. The firm issued a hold rating on the biotechnology company’s stock. Several other research firms also recently weighed in on AXON. TheStreet downgraded Axon Enterprise from a b- rating to a c+ rating in a research […]